Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

168
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
168

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

On the crossroads of interdisciplinary medicine in amyloidosis - study protocol for a single-center interdisciplinary registry study.

PloS one·2026
Same author

Photon-counting CT vs V/Q SPECT for lobar perfusion quantification in chronic thromboembolic pulmonary hypertension.

European radiology·2026
Same author

Myocardial Perfusion SPECT 2024 in Germany: Results of the 10th Survey.

Nuklearmedizin. Nuclear medicine·2025
Same author

The German Cancer Consortium (DKTK) multi-center prospective phase 1/2 <sup>68</sup>Ga-PSMA-11 PET-imaging trial in newly-diagnosed high-risk prostate cancer: Safety and diagnostic accuracy compared to histopathology and their impact on patient management.

European journal of nuclear medicine and molecular imaging·2025
Same author

Confounding by indication in observational studies investigating glucocorticoid-associated adverse events in patients with rheumatoid arthritis: a systematic literature review including an assessment of E-values.

Annals of the rheumatic diseases·2025
Same author

Medical Expert Knowledge Meets AI to Enhance Symptom Checker Performance for Rare Disease Identification in Fabry Disease: Mixed Methods Study.

JMIR AI·2025

相关实验视频

Updated: Jul 9, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.2K

在巨细胞动脉炎中,基酸莫菲蒂尔.

Anne Pankow1,2, Sena Sinno2, Thorsten Derlin3

  • 1Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Frontiers in medicine
|November 29, 2023
PubMed
概括

菌酸莫菲提尔 (MMF) 在患有巨细胞动脉炎 (GCA) 的患者中有效诱导缓解. 这种淋巴细胞特异性免疫抑制疗法在一系列病例中显示了降低CRP水平和持续的疾病控制.

关键词:
基酸莫菲蒂尔是什么?一系列的案例系列.巨细胞动脉炎的发生影像成像技术 影像成像技术血管炎是一种血管炎.

更多相关视频

Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
06:57

Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis

Published on: May 12, 2023

2.2K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.4K

相关实验视频

Last Updated: Jul 9, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.2K
Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
06:57

Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis

Published on: May 12, 2023

2.2K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.4K

科学领域:

  • 类风湿病学 类风湿病学
  • 免疫学 免疫学 免疫学
  • 内部医学 内部医学

背景情况:

  • 巨细胞动脉炎 (GCA) 是一种系统性血管炎,影响大动脉,淋巴细胞功能异常与其致病症有关.
  • 菌酸莫菲提尔 (MMF) 是一种针对淋巴细胞特异性免疫抑制剂,向因氨酸单酸脱酶.

研究的目的:

  • 评估Mycophenolate mofetil (MMF) 在被诊断为巨细胞关节炎 (GCA) 的患者中实现疾病缓解的疗效.

主要方法:

  • 在2010年至2023年期间,七名GCA患者接受MMF治疗的回顾性病例系列.
  • 通过双重超声波,18F-FDG PET,MRI和/或活检确认诊断.
  • 主要终点包括复发率,3-6个月和6-12个月的CRP水平以及缓解持续时间.

主要成果:

  • 所有患者都表现出动脉血管的炎症活性,通过成像或活检得到证实.
  • 在MMF开始后的3-6个月和6-9个月,C-反应蛋白 (CRP) 水平显著下降.
  • 在研究期间,所有七名患者的疾病完全缓解.

结论:

  • 菌酸莫菲蒂尔 (MMF) 是一种有希望的有效治疗方法,可以控制巨细胞关节炎 (GCA) 的疾病活性.
  • 通过随机对照试验进行进一步的调查是有必要的,以证实这些发现.